Massive Bio works with a number of key partners around the world to deliver the best treatment options for people diagnosed with cancer. Through these collaborative relationships, patients, family members, and physicians worldwide have easy access to Massive Bio’s proprietary SYNERGY AI® clinical trial matching system and Virtual Tumor Board services. This provides assurance that no matter where patients live, they receive the latest available and most effective therapies for their unique situations.
Philips Healthworks is an accelerator program from Philips which aims to tackle some of the biggest and most complex challenges in healthcare. It offers aspiring entrepreneurs access to healthcare partners, global innovation hubs and technology platforms that, in turn, help startups, de-risk and accelerate time-to-revenue.
Optimal Research provides Just-in-Time clinical trial access solutions to sponsors, sites and patients involved in cancer research or looking for options. Its global site community can activate a clinical trial in 2-weeks from patient pre-qualification assuring every cancer patient can access any trial made available Just-in-Time by sponsors.
War Memorial Hospital has served communities for more than 100 years and employs more than 880 individuals who are deeply committed to delivering patient-focused care. War Memorial Hospital believes in purpose, worthwhile work and making a difference in its local and regional communities.
Clinerion is the worldwide leader in medical data informatics, improving efficiency in patient search and identification, increasing effectiveness in clinical research, and accelerating the process of drug development. Massive Bio's partnership with Clinerion offers access to oncology patient insights for site outreach and identification of cohorts for trial site selection and patient recruitment.
In collaboration with Dr. Zeynep Gumus and her lab at the Icahn Institute of Genetics and Genomic Sciences, Massive Bio performs vendor-neutral evaluations of molecular profiling technologies. The goal is to make reports easier to understand for both the local oncologists and patient, which leads to increased adoption of targeted treatments for patient’s.
Admera Health is an advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing and digital health. Utilizing next generation technology platforms and advanced bioinformatics, it seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions.
Hematology Oncology Associates was established in Palm Beach County over 35 years ago, and has grown to include 7 Board Certified Hematologist and Oncologists in 3 convenient locations. Their goal is to provide state of the art cancer treatments, and they specialize in the treatment of coagulation blood disorders, leukemias and other hematologic benign conditions.
Intergen develops patient-specific tests and participate in diagnosis and treatment development of genetic diseases. They conduct more than 1,500 varieties of genetic testing; Massive Bio is a channel partner of Intergen to provide tumor board services for already profiled patients.
We leverage SecondOpinionExpert’s cutting edge information technology and network of top medical experts with Massive Bio’s world-class multidisciplinary cancer team of medical oncologists, molecular diagnostic scientists, reimbursement experts, and data scientists. Our partnership will make precision oncology accessible, affordable, and personalized for patients.
Beat19 is an IRB approved research study centered around learning and understanding the effects of coronavirus (COVID-19) on cancer patients. Surveys are administered daily asking patients about their symptoms and medications related to COVID-19. All findings will be shared by the Beat19 team in a comprehensive report at the conclusion of the study.
Remed Assistance operates in Europe, Middle East, and elsewhere worldwide to provide value-added medical tourism, health, and insurance services. Massive Bio expands its outreach by leveraging Remed Assistance’s vast international insurer network, granting their clients easy access to Massive Bio and our array of services.
Anadolu Medical Center provides healthcare services to patients from 30 countries in a most comprehensive and modern way. Massive Bio reviews complex cases for patients in Anadolu Center’s network who do not have the ability to come to the United States for care, but still want access to leading therapies they can receive at home.
Neolife is a leader in the oncology medical services market in Romania and one of the reference clinics for healthcare services in Central and Eastern Europe. Neolife and Massive Bio joined forces to support advanced staged cancer patients who require extensive treatment analysis US-based experts.
Genomize is a young, dynamic, and fast-growing biotech-startup specializing in genome-level data production and analysis. The company delivers years of bioinformatics know-how for project-specific needs in the pharmaceutical industry and multiple academic settings.
Egypt Assistance was established in 2003 as a subsidiary of Remed Assistance. Egypt Assistance provides a wide range of services to its clients, not only in Egypt but also in neighboring countries, especially UAE, Tunisia, and Morocco. They specialize in coordinating local and international travel, medical, legal assistance, and/or cost containment needs for their clients.
Redox Engine’s partnership allows us to exchange information between multiple systems, breaking down barriers that would cause delays in treatment planning. By linking to each hospital's raw HL7 formatted data, and translating it into a standardized nomenclature, Redox enables Massive Bio to create a platform that works with many different electronic medical record systems.